Asthma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Children:
- Children aged 5 to 16 years
- Children who have been diagnosed with asthma, allergic rhinitis (hay fever), or both by a lung or allergy specialist, with symptoms lasting at least 4 weeks
- Children whose parent or guardian has signed the consent form agreeing to take part
- Children who are able to understand and fill out a questionnaire
- Children who are patients (either visiting or admitted) at the Pediatrics Department of Renji Hospital in Shanghai
Parents or Caregivers:
- The main caregiver of the child taking part in the trial
- Caregivers who were present at the hospital on the day of the child's visit
- Caregivers who have signed the consent form agreeing to take part
- Caregivers who are able to understand and fill out a questionnaire
Who may not be able to join:
Children:
- Children who are unlikely to follow the study requirements consistently
- Children who are already receiving a specific allergy treatment called immunotherapy at another hospital
- Children who are not able to read and complete the questionnaire on their own
- Children who are unable to continue follow-up visits or have stopped their treatment
Parents or Caregivers:
- Caregivers who do not wish to sign the consent form
- Caregivers who are unable to complete the questionnaire due to health reasons or literacy level
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Wenjing Zhou, Renji Hospital, School of Medicine, Shanghai Jiaotong University
Phone: +31685281032
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Asthma control level for asthmatic children; Severity assessment of allergic rhinitis; EQ-5D-Y-3L for assessing health-related quality of life; EQ-VAS for assessing health-related quality of life; PAQLQ for assessing health-related quality of life in children with asthma; JRQLQ-No. 1 for assessing health-related quality of life in children with allergic rhinitis
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.